Appia Bio: Funding, Investors & Team (Oct 2026)
Appia Bio is an early-stage biotechnology company based in Los Angeles, California. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
Appia Bio has raised $52.0M across 1 funding round on record, the most recent an undisclosed round of $52.0M announced in May 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Appia Bio Company Profile and Key Stats
Latest funding round on record: May 2021.
Appia Bio Funding Rounds
Appia Bio Founders and Leadership Team
No contact details are on record for this team yet.
Appia Bio Funding Compared to Other Biotechnology Startups
Appia Bio's latest round of $52.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Appia Bio in Biotechnology and Los Angeles
Companies Similar to Appia Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Appia Bio Funding FAQs
What does Appia Bio do?
Appia Bio is an early-stage biotechnology company based in Los Angeles, California. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
How much funding has Appia Bio raised?
Appia Bio has raised $52.0M across 1 round on record. The most recent is an undisclosed round of $52.0M announced in May 2021.
When did Appia Bio last raise funding?
Appia Bio's most recent funding round on record is an undisclosed round of $52.0M, announced in May 2021.
Who is the CEO of Appia Bio?
JeenJoo Kang is listed as CEO at Appia Bio.
Where is Appia Bio headquartered?
Appia Bio is based in Los Angeles, California, United States.
How many employees does Appia Bio have?
Appia Bio is in the 11-50 employee band.
How does Appia Bio's funding compare to other Biotechnology startups?
Appia Bio's latest round of $52.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Appia Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Appia Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.